Delivery Order SPE2DB24D2205-SPE2DB25FEHXC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,987.51 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,376.87 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $1,552.79 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This competitively awarded, firm fixed-price contract is not set-aside and was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,745.29 on August 20, 2025, for the supply of Methylphenidate ER(CD) 30mg capsules (100 count). This is a firm fixed-price, non-set-aside contract with a completion date of August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units) with a ceiling value of $2,917.54. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,006.80 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg in a quantity of 100 capsules. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Methylphenidate ER(LA) 20mg capsules (100 count) with a ceiling value of $1,421.35. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and running through December 2026. The delivery order was competitively awarded with no set-aside designation and is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on April 21, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Methylphenidate ER(LA) 30mg capsules in a quantity of 100 units. The contract carries a firm fixed price ceiling value of $1,374.60 and is scheduled for completion by April 22, 2025. This is a competitively awarded, non-set-aside delivery order with no small business...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,205.38 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units) under a firm fixed-price contract type. This non-set-aside award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHXCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.28 for Methylphenidate ER(LA) 10mg capsules (100-count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, supplying a broad portfolio of medications and medical supplies to support military and veteran healthcare systems. The Methylphenidate order fulfills immediate pharmaceutical needs for the Defense Health Agency and other federal healthcare customers. As one of multiple contractors selected for the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen demonstrates its established capability to meet federal procurement requirements through competitive award processes, with a track record of delivering diverse pharmaceutical products ranging from generic medications to specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/23/25 |